Search

Editors

Richard L. Cassin Publisher and Editor

Andy Spalding Senior Editor

Jessica Tillipman Senior Editor

Elizabeth K. Spahn Editor Emeritus

Cody Worthington Contributing Editor

Julie DiMauro Contributing Editor

Thomas Fox Contributing Editor

Marc Alain Bohn Contributing Editor

Bill Waite Contributing Editor

Shruti J. Shah Contributing Editor

Russell A. Stamets Contributing Editor

Richard Bistrong Contributing Editor 

Eric Carlson Contributing Editor

Bill Steinman Contributing Editor

Aarti Maharaj Contributing Editor


Connect
FCPA Blog Daily News

Entries in Glaxo (29)

Friday
Oct182013

U.S., China enforcement crossfire creates new risks

At the beginning of this year, China's president Xi Jinping promised to fight both "tigers" and "flies" -- high-ranking and low-ranking corrupt officials -- in his crackdown on corruption. Since then, the anti-graft campaign has led to the conviction of Bo Xilai and to the front-page investigations of foreign companies in the pharmaceutical and oil and gas sectors, among others.

Click to read more ...

Wednesday
Sep042013

Bribery part of GSK business plan, China police say

Image courtesy of GlaxoSmithKlineA police investigation in China has found that drugmaker GlaxoSmithKline's alleged bribery of doctors ‘was coordinated by the British company and was not the work of individual employees,’ according to a report Tuesday by Reuters.

Click to read more ...

Monday
Aug262013

Drug sellers ‘take vacations’ amid China anti-graft campaign 

Pharmas have told their sales teams to halt all activity in China to avoid being caught in the nationwide “enforcement storm,” according to the Guangdong-based Yangcheng Evening News.

Click to read more ...

Wednesday
Aug212013

GSK In China: A Game Changer in Compliance

The entry of the Chinese government into the international fight against corruption and bribery is truly a game-changer. While there may be many reasons for this very public move by the Chinese government, it is clear that foreign companies are now on notice. Doing business the old fashioned way will no longer be tolerated.

Click to read more ...

Sunday
Aug112013

Sanofi hit with China bribe probe

China state media reported Saturday that French drugmaker Sanofi SA is under investigation for allegedly bribing doctors to increase sales.

Click to read more ...

Thursday
Aug082013

Can we relax yet?

Professor Peter J. Henning of Wayne State University Law School (Photo courtesy of Wayne Law)Over the last decade, since the passage of the Sarbanes-Oxley Act in 2002, publicly traded corporations have poured significant resources into their compliance programs to prevent wrongdoing . . .

Click to read more ...

Thursday
Aug082013

Problem du jour: Dealing with travel agents

The risks of working with travel agents are coming to light amid recent allegations that at least one agent in China and maybe many more used slush funds to make illicit payments on behalf of a pharmaceutical client.

Click to read more ...

Wednesday
Aug072013

Quick look at Big Pharma’s U.S. rap sheet

Recent turbulence in China for drug makers follows big problems for members of the industry in the United States, where they've paid billions in criminal fines and civil penalties.

Click to read more ...

Monday
Aug052013

Baxter confirms China payment offenses

Drug and medical device maker Baxter International Inc. told the Wall Street Journal last week that following whistleblower complaints, it investigated allegations and found improper expense payments by a China joint venture.

Click to read more ...

Thursday
Aug012013

Spread of GSK contagion to other countries, industries now 'highly likely'

The GSK China bribery investigators are probably going to name several other significant foreign companies in the coming days and weeks. The State Administration for Industry & Commerce (SAIC) has already announced that investigations into several other pharmaceutical companies have begun. And authorities have visited three multinational drug companies.

Click to read more ...

Tuesday
Jul302013

With flashy pharma sweep, China steps into global enforcement role

Here's a thoughtful comment from a U.S.-based compliance professional who asked not to be named:

Click to read more ...

Saturday
Jul272013

More arrests, confessions reported in China pharma scandal

China state media reported Friday that police have detained 18 more people in the growing bribery investigation of U.K. drug maker GlaxoSmithKline.

Click to read more ...